Help keep Salon independent

Topic: Stephen Hahn

Donald Trump and Deborah Birx (Getty Images/Salon)

Birx: Trump response cost 400K+ lives

Igor Derysh
Donald Trump watching Fox News (Photo illustration by Salon/Getty Images/Fox News)

Psychologist: Take coup threat seriously

Igor Derysh
The U.S. Department of Health and Human Services building is pictured in Washington on Monday, July 13, 2020 (Caroline Brehman/CQ-Roll Call, Inc via Getty Images)

Top HHS lawyer has deep industry ties

Igor Derysh
FDA Commissioner Stephen Hahn addresses the media during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. President Donald Trump announced that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances. (Pete Marovich/Getty Images)

FDA's PR meltdown continues

Roger Sollenberger
Advertisement:
FDA Commissioner Stephen Hahn addresses the media during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. President Donald Trump announced that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances. (Pete Marovich/Getty Images)

FDA head wants to fast-track vaccine

Matthew Rozsa
One America News Network | Food & Drug Administration (Graphics collage by Salon/WiikiCommons/One America News Network)

FDA fires spokesperson for misinfo

Roger Sollenberger
One America News Network | Food & Drug Administration (Graphics collage by Salon/WiikiCommons/One America News Network)

Former OANN reporter gets FDA post

Roger Sollenberger
President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances. (Pete Marovich/Getty Images)

FDA head apologizes for hyping treatment

Roger Sollenberger
Advertisement: